MCI syndicate to offer infectious disease liability insurance cover
Specialist liability underwriter Medical & Commercial International (MCI) announces the la...
Medical & Commercial International
The liability environment does not stand still. With ever-increasing regulation and more complex litigation it is as important as ever to partner with specialists who both understand the changing landscape and can provide long term tailored solutions.
Medical & Commercial International (MCI) meet this challenge through a team of underwriters experienced in underwriting specialised general & medical liability on an international basis.
Our aim is clear: to provide the highest calibre of liability insurance products to those industries and risks where in-depth expertise is key to adding value.
Syndicate 1902
MCI have received approval from Lloyds Syndicate 1902 to underwrite business with an inception date on or after 1st January 2022.
The MCI Syndicate will underwrite our existing core Medical & Commercial Liability classes as well as launching several new and innovative products which have scientific and research-driven underwriting characteristics.
The vision for Syndicate 1902 is to create a global leader in science and research-led risk transfer with superior returns in evolving risk classes.
Products
Pharmaceutical Liability Insurance
Despite recent economic pressures, the global pharmaceutical industry is forecast to grow significantly over the next 5-10 years.
Medical Device Liability Insurance
The term ‘medical device’ covers a vast range of equipment, from simple tongue depressors to the most sophisticated life-support products.
Clinical Trials Insurance
Within the life science industry successful product research is the key to sustaining a meaningful product pipeline.
Medical Malpractice Liability Insurance
New procedures are practiced and trialled every week with standards and expectations higher than ever.
Commercial Liability Insurance
Whilst the language used in liability risk management has evolved since Dr. Johnson’s era, the dilemma has not.
Infectious Disease Liability
Typically, we fight off minor infections with no long-term consequences, but these pathogens also have the power to cause potentially devastating outbreaks.
